Latest Vital signs Stories

Law Offices of James Scott Farrin Vice President and Daughter Work Together to Make a Difference Raleigh, NC (PRWEB) May 17, 2013 On May 8, 2013, Governor McCrory signed Senate Bill 98 into law which expands the newborn screening program to include screening for congenital heart disease utilizing pulse oximetry. Pulse oximetry is a simple, inexpensive, non-invasive test that monitors the amount of oxygen in blood. It’s so simple and effective many institutions refer to it as “the 5th...

Assurance Biosense, Inc announces that they have received FDA 510(k) clearance to send their unique nasal ala pulse oximetry sensor to market. Glastonbury, CT (PRWEB) April 17, 2013 Assurance Biosense Receives FDA 510(k) Clearance to Market Alar Sensor -Unique Nasal Ala Pulse Oximetry Sensor- -Alar Sensing Promises High-Levels of Accuracy, Stability and Monitoring Reliability- -Sensor Compatible with Large, Existing Installed Base of Pulse Oximeters- Assurance Biosense, Inc., a subsidiary...

EVERETT, Wash., May 15, 2012 /PRNewswire/ -- Fluke Biomedical announced today the newest addition to their ProSim family of patient monitor quality-assurance testing and troubleshooting tools, the SPOT Light SpO2 Functional Tester. Citing a record 15-second preventive maintenance (PM) test for SpO2 patient monitor functionality, the new ProSim SPOT Light is the fastest SpO2 functional tester ever achieved by this industry-leading company. (Photo:...

Inaccurate blood pressure measurements due to faulty technique impact hypertension treatment decisions Because some clinicians fail to stick to official recommendations for blood pressure monitoring, a number of patients are misclassified, which could have an impact on decisions about their treatment. According to Gretchen Ray and colleagues, from the University of New Mexico College of Pharmacy, when routine blood pressure monitoring in clinics is compared with measurements based on the...

MINNEAPOLIS, Jan. 6, 2011 /PRNewswire/ -- Nonin Medical, Inc., the inventor of fingertip pulse oximetry and a leader in noninvasive physiological monitoring, today announced that the Onyx® II Model 9560 Continua(TM)-Certified, Bluetooth® wireless fingertip pulse oximeter has received Microsoft® HealthVault(TM) certification. Microsoft HealthVault is Microsoft Corporation's Web-based platform that allows consumers to upload from their health and wellness devices vital signs and...

IRVINE, Calif. and KAUFERING, Germany, Aug. 20 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, and GS Elektromedizinische Gerate G. Stemple GmbH, a German developer and manufacturer of innovative medical equipment for the Emergency Medical Services (EMS), today jointly announced a worldwide technology licensing agreement to integrate Masimo Rainbow SET Pulse CO-Oximetry into corpuls(R)...

GE Healthcare, a unit of General Electric Company, has completed the acquisition of Vital Signs, a provider of medical products applicable to a wide range of care areas such as anesthesia, respiratory, sleep therapy and emergency medicine. Vital Signs will become part of GE Healthcare's clinical systems business, a provider of advanced technologies for patient monitoring, anesthesia delivery and acute respiratory care. The strong strategic fit between the two businesses is expected to offer...

TOTOWA, N.J., Sept. 24, 2008 (GLOBE NEWSWIRE) -- Vital Signs, Inc. (Nasdaq:VITL) today announced that it will hold a special meeting of its shareholders on Wednesday, October 29, 2008, at 10:00 A.M. local time, at the offices of its counsel, Lowenstein Sandler PC, 65 Livingston Avenue, Roseland, New Jersey. The purpose of the special meeting is for Vital Signs, Inc. shareholders to consider and vote on the proposal to approve the previously disclosed Agreement and Plan of Merger, dated as of...

GE Healthcare, a unit of General Electric Company (NYSE:GE), and Vital Signs, Inc. (NASDAQ:VITL) announced today that they have entered into a definitive merger agreement for GE to acquire Vital Signs. Under the terms of the agreement, shareholders of Vital Signs will receive $74.50 per share in cash for each Vital Signs share they own. Vital Signs is a global provider of medical products applicable to a wide range of care areas such as anesthesia, respiratory, sleep therapy and emergency...